|
Volumn 21, Issue 8, 2006, Pages 630-641
|
Tourette syndrome: Diagnosis, strategies, therapies, pathogenesis, and future research directions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
ATOMOXETINE;
BACLOFEN;
BOTULINUM TOXIN;
CLOMIPRAMINE;
CLONIDINE;
DOPAMINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
DOPAMINE TRANSPORTER;
FLUOXETINE;
FLUPHENAZINE;
FLUVOXAMINE;
GUANFACINE;
INTERLEUKIN 12;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
PERGOLIDE;
PIMOZIDE;
PLACEBO;
RISPERIDONE;
SEROTONIN RECEPTOR;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
VESICULAR MONOAMINE TRANSPORTER 2;
ADJUVANT THERAPY;
ANXIETY;
ANXIETY DISORDER;
ARTICLE;
ATHETOSIS;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
BLINKING;
BODY WEIGHT DISORDER;
BRAIN DEPTH STIMULATION;
BRAIN SURGERY;
CHOREA MINOR;
CLINICAL TRIAL;
COGNITIVE THERAPY;
COMORBIDITY;
DEPRESSION;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DIZZINESS;
DOPAMINE RELEASE;
DOPAMINERGIC SYSTEM;
DRUG EFFICACY;
DRUG ERUPTION;
DYSKINESIA;
DYSTONIA;
EARLY DIAGNOSIS;
EXTRAPYRAMIDAL SYMPTOM;
GABAERGIC SYSTEM;
GENE FUNCTION;
GENETIC PREDISPOSITION;
GILLES DE LA TOURETTE SYNDROME;
HEALTH EDUCATION;
HUMAN;
LEARNING DISORDER;
MOTOR CONTROL;
MYOCLONUS;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OBSESSIVE COMPULSIVE DISORDER;
PATHOGENESIS;
PATHOLOGICAL ANATOMY;
PERSEVERATION;
PHENOTYPE;
POSITRON EMISSION TOMOGRAPHY;
PREVALENCE;
PRIORITY JOURNAL;
RISK FACTOR;
SCREENING TEST;
SEDATION;
SIDE EFFECT;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SNIFFING;
SOCIAL DISABILITY;
SUICIDAL BEHAVIOR;
SYMPOSIUM;
THERAPY RESISTANCE;
TREMOR;
WEIGHT GAIN;
CHILD;
COMORBIDITY;
HUMANS;
RESEARCH;
TOURETTE SYNDROME;
UNITED STATES;
|
EID: 33748060175
PISSN: 08830738
EISSN: None
Source Type: Journal
DOI: 10.1177/08830738060210080601 Document Type: Article |
Times cited : (10)
|
References (0)
|